Publications by Nenad Bogdanovic
209 publications found
Original articles
Stress, depression, and risk of dementia - a cohort study in the total population between 18 and 65 years old in Region Stockholm
Alzheimers Res Ther, 15 (1), 161
DOI 10.1186/s13195-023-01308-4, PubMed 37779209
Alzheimer's disease biomarker profiling in a memory clinic cohort without common comorbidities
Brain Commun, 5 (5), fcad228
DOI 10.1093/braincomms/fcad228, PubMed 37680670
Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains
Mol Psychiatry, 28 (3), 1272-1283
DOI 10.1038/s41380-022-01875-2, PubMed 36447011
Autophagy Impairment in App Knock-in Alzheimer's Model Mice
Front Aging Neurosci, 14, 878303
DOI 10.3389/fnagi.2022.878303, PubMed 35663567
Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort
J Alzheimers Dis, 86 (3), 1459-1470
DOI 10.3233/JAD-215504, PubMed 35213378
Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study
J Alzheimers Dis, 89 (3), 825-834
DOI 10.3233/JAD-220407, PubMed 35938253
Vitamin D in Alzheimer's Disease: Low Levels in Cerebrospinal Fluid Despite Normal Amounts in Serum
J Alzheimers Dis, 86 (3), 1301-1314
DOI 10.3233/JAD-215536, PubMed 35180126
Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71
Front Aging Neurosci, 13, 735334
DOI 10.3389/fnagi.2021.735334, PubMed 34867272
Diagnostic accuracy and clinical applicability of the Swedish version of the 4AT assessment test for delirium detection, in a mixed patient population and setting
BMC Geriatr, 21 (1), 568
DOI 10.1186/s12877-021-02493-3, PubMed 34663229
Confusion, cognitive impairment, and spinal cord compression caused by plasmacytoma: a case report
BMC Neurol, 21 (1), 303
DOI 10.1186/s12883-021-02332-3, PubMed 34362322
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease
Transl Neurodegener, 10 (1), 18
DOI 10.1186/s40035-021-00244-3, PubMed 34099032
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease
Front Aging Neurosci, 12, 608628
DOI 10.3389/fnagi.2020.608628, PubMed 33488383
Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms
J Alzheimers Dis, 79 (1), 311-321
DOI 10.3233/JAD-201018, PubMed 33252081
Insulin-Independent and Dependent Glucose Transporters in Brain Mural Cells in CADASIL
Front Genet, 11, 1022
DOI 10.3389/fgene.2020.01022, PubMed 33101365
Start low, go slow, but look far: the case of geriatric medicine in Balkan countries
Eur Geriatr Med, 11 (5), 869-878
DOI 10.1007/s41999-020-00350-x, PubMed 32588380
Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9
Mol Psychiatry, 26 (10), 5609-5619
DOI 10.1038/s41380-020-0817-2, PubMed 32581318
[Alzheimer's disease - the most common cause of dementia]
Lakartidningen, 117
PubMed 32154904
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J Alzheimers Dis, 77 (2), 831-842
DOI 10.3233/JAD-200237, PubMed 32741818
Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
Alzheimers Res Ther, 11 (1), 99
DOI 10.1186/s13195-019-0557-1, PubMed 31805990
The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease
Mol Cell Proteomics, 19 (1), 128-141
DOI 10.1074/mcp.RA119.001737, PubMed 31699905
Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365, PubMed 31430334
Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis
Eur J Nucl Med Mol Imaging, 46 (6), 1276-1286
DOI 10.1007/s00259-019-04297-5, PubMed 30915522
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein
Sci Rep, 9 (1), 2460
DOI 10.1038/s41598-018-36650-3, PubMed 30792413
Higher Vitamin D Levels Are Associated with Better Attentional Functions: Data from the NorCog Register
J Nutr Health Aging, 23 (8), 725-731
DOI 10.1007/s12603-019-1220-z, PubMed 31560030
Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis
J Alzheimers Dis, 68 (2), 571-582
DOI 10.3233/JAD-181144, PubMed 30814355
Meta-analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk loci
Sci Rep, 8 (1), 18088
DOI 10.1038/s41598-018-36429-6, PubMed 30591712
Hippocampal expression of cell-adhesion glycoprotein neuroplastin is altered in Alzheimer's disease
J Cell Mol Med, 23 (2), 1602-1607
DOI 10.1111/jcmm.13998, PubMed 30488668
Increased Active OMI/HTRA2 Serine Protease Displays a Positive Correlation with Cholinergic Alterations in the Alzheimer's Disease Brain
Mol Neurobiol, 56 (7), 4601-4619
DOI 10.1007/s12035-018-1383-3, PubMed 30361890
Hypothesis related to the regulation of inducible nitric oxide synthase during carotid endarterectomy
Med Hypotheses, 122, 16-18
DOI 10.1016/j.mehy.2018.10.011, PubMed 30593403
Hippocampal granule cell loss in human chronic alcohol abusers
Neurobiol Dis, 120, 63-75
DOI 10.1016/j.nbd.2018.08.011, PubMed 30189262
Effects of Alcohol Abuse on Proliferating Cells, Stem/Progenitor Cells, and Immature Neurons in the Adult Human Hippocampus
Neuropsychopharmacology, 43 (4), 690-699
DOI 10.1038/npp.2017.251, PubMed 29052615
Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
Alzheimers Res Ther, 9 (1), 57
DOI 10.1186/s13195-017-0279-1, PubMed 28764767
Finding of increased caudate nucleus in patients with Alzheimer's disease
Acta Neurol Scand, 137 (2), 224-232
DOI 10.1111/ane.12800, PubMed 28741672
Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium
J Alzheimers Dis, 55 (1), 371-379
DOI 10.3233/JAD-160461, PubMed 27662296
Maturation and processing of the amyloid precursor protein is regulated by the potassium/sodium hyperpolarization-activated cyclic nucleotide-gated ion channel 2 (HCN2)
Biochem Biophys Res Commun, 483 (1), 352-358
DOI 10.1016/j.bbrc.2016.12.140, PubMed 28017718
Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease
Alzheimers Dement, 13 (4), 419-430
DOI 10.1016/j.jalz.2016.08.006, PubMed 27693181
Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons
Front Neuroanat, 9, 126
DOI 10.3389/fnana.2015.00126, PubMed 26441556
Reduced sympathetic response to head-up tilt in subjects with mild cognitive impairment or mild Alzheimer's dementia
Dement Geriatr Cogn Dis Extra, 5 (1), 107-15
DOI 10.1159/000375297, PubMed 25873932
Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium
J Neural Transm (Vienna), 122 (7), 957-72
DOI 10.1007/s00702-014-1304-1, PubMed 25239189
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions
Acta Neuropathol, 127 (3), 407-18
DOI 10.1007/s00401-013-1239-x, PubMed 24442578
The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ
Acta Neuropathol Commun, 1, 60
DOI 10.1186/2051-5960-1-60, PubMed 24252272
Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium
Neuropathol Appl Neurobiol, 39 (2), 166-78
DOI 10.1111/j.1365-2990.2012.01272.x, PubMed 22471883
VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival
Sci Rep, 3, 2053
DOI 10.1038/srep02053, PubMed 23792494
APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38
Acta Neuropathol, 124 (6), 809-21
DOI 10.1007/s00401-012-1061-x, PubMed 23143229
Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain
Free Radic Res, 46 (12), 1490-5
DOI 10.3109/10715762.2012.728286, PubMed 22962855
Localization of cholesterol, amyloid and glia in Alzheimer's disease transgenic mouse brain tissue using time-of-flight secondary ion mass spectrometry (ToF-SIMS) and immunofluorescence imaging
Acta Neuropathol, 125 (1), 145-57
DOI 10.1007/s00401-012-1046-9, PubMed 22996963
Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease
J Cell Mol Med, 16 (8), 1686-700
DOI 10.1111/j.1582-4934.2011.01441.x, PubMed 21883897
The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium
Exp Gerontol, 47 (11), 825-33
DOI 10.1016/j.exger.2012.06.001, PubMed 22705312
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
Neurology, 79 (3), 229-36
DOI 10.1212/WNL.0b013e31825fdf18, PubMed 22700814
Claudin expression profile separates Alzheimer's disease cases from normal aging and from vascular dementia cases
J Neurol Sci, 322 (1-2), 184-6
DOI 10.1016/j.jns.2012.05.031, PubMed 22664153
A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease
J Neural Transm (Vienna), 119 (7), 833-42
DOI 10.1007/s00702-012-0823-x, PubMed 22622366
Identification of two novel synaptic γ-secretase associated proteins that affect amyloid β-peptide levels without altering Notch processing
Neurochem Int, 61 (1), 108-18
DOI 10.1016/j.neuint.2012.03.016, PubMed 22521230
Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease
Dement Geriatr Cogn Disord, 33 (2-3), 174-88
DOI 10.1159/000338181, PubMed 22572791
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease
Dement Geriatr Cogn Disord, 33 (1), 18-28
DOI 10.1159/000336051, PubMed 22377499
The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ
Neurobiol Aging, 33 (5), 1010.e1-13
DOI 10.1016/j.neurobiolaging.2011.10.022, PubMed 22118948
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration
Arch Neurol, 68 (4), 488-97
DOI 10.1001/archneurol.2011.53, PubMed 21482928
Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers
J Alzheimers Dis, 24 (3), 495-506
DOI 10.3233/JAD-2011-101563, PubMed 21297272
Self- and informant ratings of personality in mild cognitive impairment, reviewed
Dement Geriatr Cogn Disord, 32 (6), 387-93
DOI 10.1159/000330695, PubMed 22301462
Effect of environmental enrichment on morphology of deep layer III and layer V pyramidal cells of occipital cortex in oldest-old rat - A quantitative golgi cox study
Coll Antropol, 35 Suppl 1, 253-8
PubMed 21648343
PPARγ co-activator-1α (PGC-1α) reduces amyloid-β generation through a PPARγ-dependent mechanism
J Alzheimers Dis, 25 (1), 151-62
DOI 10.3233/JAD-2011-101356, PubMed 21358044
Semantic dementia with lower motor neuron disease showing FTLD-TDP type 3 pathology (sensu Mackenzie)
Neuropathology, 31 (3), 271-9
DOI 10.1111/j.1440-1789.2010.01154.x, PubMed 21029204
Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains
J Cell Mol Med, 14 (5), 1088-100
DOI 10.1111/j.1582-4934.2009.00999.x, PubMed 20041969
Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease
Acta Neuropathol, 120 (2), 185-93
DOI 10.1007/s00401-010-0690-1, PubMed 20419305
Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of Abeta42 and Alzheimer's disease neuropathology
Acta Neuropathol, 119 (5), 543-54
DOI 10.1007/s00401-010-0661-6, PubMed 20198479
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
Nat Genet, 42 (3), 234-9
DOI 10.1038/ng.536, PubMed 20154673
Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract
Mech Ageing Dev, 131 (2), 105-10
DOI 10.1016/j.mad.2009.12.007, PubMed 20064547
Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations
J Neuropathol Exp Neurol, 68 (12), 1282-93
DOI 10.1097/NEN.0b013e3181c1da10, PubMed 19915487
Kinesin light chain 1 gene haplotypes in three conformational diseases
Neuromolecular Med, 12 (3), 229-36
DOI 10.1007/s12017-009-8103-0, PubMed 19911314
CD147, a gamma-secretase associated protein is upregulated in Alzheimer's disease brain and its cellular trafficking is affected by presenilin-2
Neurochem Int, 56 (1), 67-76
DOI 10.1016/j.neuint.2009.09.003, PubMed 19751784
Is the role of estrogens and estrogen receptors in epilepsy still underestimated?
Med Hypotheses, 73 (5), 703-5
DOI 10.1016/j.mehy.2009.03.051, PubMed 19493633
Cortical morphometric subclassification of frontotemporal lobar degeneration
AJNR Am J Neuroradiol, 30 (6), 1233-9
DOI 10.3174/ajnr.A1545, PubMed 19346314
Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium
Acta Neuropathol, 117 (6), 635-52
DOI 10.1007/s00401-009-0523-2, PubMed 19330340
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium
Acta Neuropathol, 117 (3), 309-20
DOI 10.1007/s00401-009-0485-4, PubMed 19184666
Articulatory agility in cognitive decline
Folia Phoniatr Logop, 61 (5), 269-74
DOI 10.1159/000235649, PubMed 19696488
Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk
Mol Med Rep, 2 (6), 989-92
DOI 10.3892/mmr_00000203, PubMed 21475932
Personality features in subjective cognitive impairment and mild cognitive impairment--early indicators of dementia?
Dement Geriatr Cogn Disord, 28 (6), 528-35
DOI 10.1159/000255104, PubMed 20016183
Environmental enrichment alters dentate granule cell morphology in oldest-old rat
J Cell Mol Med, 13 (8B), 1845-1856
DOI 10.1111/j.1582-4934.2008.00560.x, PubMed 19175692
Influence of environmental manipulation on exploratory behaviour in male BDNF knockout mice
Behav Brain Res, 197 (2), 339-46
DOI 10.1016/j.bbr.2008.09.032, PubMed 18951926
Association of complement factor H Y402H gene polymorphism with Alzheimer's disease
Am J Med Genet B Neuropsychiatr Genet, 147B (6), 720-6
DOI 10.1002/ajmg.b.30668, PubMed 18163432
Reduced cell number in the neocortical part of the human fetal brain in Down syndrome
Ann Anat, 190 (5), 421-7
DOI 10.1016/j.aanat.2008.05.007, PubMed 18722098
Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain
Neuroreport, 19 (11), 1085-9
DOI 10.1097/WNR.0b013e328302c858, PubMed 18596605
Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease
Arch Neurol, 65 (4), 499-505
DOI 10.1001/archneur.65.4.499, PubMed 18413473
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium
Brain Pathol, 18 (4), 484-96
DOI 10.1111/j.1750-3639.2008.00147.x, PubMed 18371174
17beta-Oestradiol stimulation of G-proteins in aged and Alzheimer's human brain: comparison with phytoestrogens
J Neuroendocrinol, 20 (5), 587-96
DOI 10.1111/j.1365-2826.2008.01696.x, PubMed 18363809
Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium
J Neuropathol Exp Neurol, 67 (2), 125-43
DOI 10.1097/nen.0b013e3181633526, PubMed 18219257
Mixed brain pathologies in dementia: the BrainNet Europe consortium experience
Dement Geriatr Cogn Disord, 26 (4), 343-50
DOI 10.1159/000161560, PubMed 18849605
Word sequence production in cognitive decline: forward ever, backward never
Logoped Phoniatr Vocol, 33 (3), 126-35
DOI 10.1080/14015430801945794, PubMed 18608881
Analysis of NR3A receptor subunits in human native NMDA receptors
Brain Res, 1186, 102-12
DOI 10.1016/j.brainres.2007.09.008, PubMed 17997397
The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association
Neurobiol Aging, 30 (4), 666-8
DOI 10.1016/j.neurobiolaging.2007.07.018, PubMed 17850927
Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease
Int J Mol Med, 20 (2), 233-9
PubMed 17611642
A temporal lobe factor in verb fluency
Cortex, 43 (5), 607-15
DOI 10.1016/s0010-9452(08)70491-x, PubMed 17715796
Severe cell reduction in the future brain cortex in human growth-restricted fetuses and infants
Am J Obstet Gynecol, 197 (1), 56.e1-7
DOI 10.1016/j.ajog.2007.02.011, PubMed 17618757
A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation
Biochem Biophys Res Commun, 358 (3), 777-82
DOI 10.1016/j.bbrc.2007.04.195, PubMed 17506994
Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study
Brain Pathol, 17 (3), 297-303
DOI 10.1111/j.1750-3639.2007.00073.x, PubMed 17465988
Occludin is overexpressed in Alzheimer's disease and vascular dementia
J Cell Mol Med, 11 (3), 569-79
DOI 10.1111/j.1582-4934.2007.00047.x, PubMed 17635647
Antioxidative effects of plant polyphenols: from protection of G protein signaling to prevention of age-related pathologies
Ann N Y Acad Sci, 1095, 449-57
DOI 10.1196/annals.1397.048, PubMed 17404057
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II
J Neural Transm (Vienna), 114 (5), 527-37
DOI 10.1007/s00702-006-0601-8, PubMed 17165101
GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptide
J Neurosci, 26 (49), 12838-46
DOI 10.1523/JNEUROSCI.1982-06.2006, PubMed 17151287
Critical role of methionine-722 in the stimulation of human brain G-proteins and neurotoxicity induced by London familial Alzheimer's disease (FAD) mutated V717G-APP(714-723)
Neuroscience, 144 (2), 571-8
DOI 10.1016/j.neuroscience.2006.10.007, PubMed 17101228
Analysis of single Alzheimer solid plaque cores by laser capture microscopy and nanoelectrospray/tandem mass spectrometry
Biochemistry, 45 (32), 9849-56
DOI 10.1021/bi060331+, PubMed 16893185
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium
J Neuropathol Exp Neurol, 65 (8), 740-57
DOI 10.1097/01.jnen.0000229986.17548.27, PubMed 16896308
Altered subcellular localization of ornithine decarboxylase in Alzheimer's disease brain
Biochem Biophys Res Commun, 344 (2), 640-6
DOI 10.1016/j.bbrc.2006.03.191, PubMed 16630547
Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma
Proc Natl Acad Sci U S A, 103 (2), 443-8
DOI 10.1073/pnas.0503839103, PubMed 16407166
Neuroglia in the inferior olivary nucleus during normal aging and Alzheimer's disease
J Cell Mol Med, 10 (1), 145-56
DOI 10.1111/j.1582-4934.2006.tb00296.x, PubMed 16563227
Total number of cells in the human newborn telencephalic wall
Neuroscience, 139 (3), 999-1003
DOI 10.1016/j.neuroscience.2006.01.005, PubMed 16516393
Towards compendia of negative genetic association studies: an example for Alzheimer disease
Hum Genet, 119 (1-2), 29-37
DOI 10.1007/s00439-005-0078-9, PubMed 16341549
Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease
Cell Death Differ, 13 (9), 1454-65
DOI 10.1038/sj.cdd.4401818, PubMed 16311508
Impaired verb fluency: a sign of mild cognitive impairment
Brain Lang, 95 (2), 273-9
DOI 10.1016/j.bandl.2005.01.010, PubMed 16246735
PTEN levels in Alzheimer's disease medial temporal cortex
Neurochem Int, 48 (2), 114-23
DOI 10.1016/j.neuint.2005.08.014, PubMed 16239049
Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain
Neurobiol Aging, 26 (6), 795-802
DOI 10.1016/j.neurobiolaging.2004.07.011, PubMed 15718037
Human monoclonal antibodies against amyloid-beta from healthy adults
Neurobiol Aging, 26 (5), 597-606
DOI 10.1016/j.neurobiolaging.2004.06.008, PubMed 15708434
High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques
Exp Neurol, 192 (1), 215-25
DOI 10.1016/j.expneurol.2004.12.015, PubMed 15698636
Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms
J Neurosci Res, 79 (3), 368-74
DOI 10.1002/jnr.20371, PubMed 15614786
19-Nortestosterone influences neural stem cell proliferation and neurogenesis in the rat brain
Eur J Neurosci, 21 (4), 871-8
DOI 10.1111/j.1460-9568.2005.03942.x, PubMed 15787693
Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains
J Neurochem, 92 (1), 171-82
DOI 10.1111/j.1471-4159.2004.02849.x, PubMed 15606906
Association of refractory complex partial seizures with a polymorphism of ApoE genotype
J Cell Mol Med, 9 (3), 698-703
DOI 10.1111/j.1582-4934.2005.tb00500.x, PubMed 16202217
Age-related increases in calcium-binding protein immunoreactivity in the cochlear nucleus of hearing impaired C57BL/6J mice
Neurobiol Aging, 25 (8), 1085-93
DOI 10.1016/j.neurobiolaging.2003.11.004, PubMed 15212833
Akt activity in Alzheimer's disease and other neurodegenerative disorders
Neuroreport, 15 (6), 955-9
DOI 10.1097/00001756-200404290-00005, PubMed 15076714
Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease
Neurosci Lett, 358 (3), 220-2
DOI 10.1016/j.neulet.2004.01.032, PubMed 15039120
Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease
Hum Genet, 114 (6), 581-7
DOI 10.1007/s00439-004-1107-9, PubMed 15034781
Beta-secretase-cleaved amyloid precursor protein in Alzheimer brain: a morphologic study
J Cell Mol Med, 8 (1), 127-34
DOI 10.1111/j.1582-4934.2004.tb00267.x, PubMed 15090268
The distribution and the modulation of tyrosine hydroxylase immunoreactivity in the lateral olivocochlear system of the guinea-pig
Neuroscience, 125 (3), 725-33
DOI 10.1016/j.neuroscience.2004.02.023, PubMed 15099686
Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease
Dement Geriatr Cogn Disord, 17 (3), 215-21
DOI 10.1159/000076359, PubMed 14739547
Molecular identification of AMY, an Alzheimer disease amyloid-associated protein
J Neuropathol Exp Neurol, 62 (11), 1108-17
DOI 10.1093/jnen/62.11.1108, PubMed 14656069
Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease
J Lipid Res, 45 (1), 186-93
DOI 10.1194/jlr.M300320-JLR200, PubMed 14523054
Amyloid precursor protein carboxy-terminal fragments modulate G-proteins and adenylate cyclase activity in Alzheimer's disease brain
Brain Res Mol Brain Res, 117 (1), 73-82
DOI 10.1016/s0169-328x(03)00292-4, PubMed 14499483
Auditory peripheral influences on calcium binding protein immunoreactivity in the cochlear nucleus during aging in the C57BL/6J mouse
Hear Res, 179 (1-2), 33-42
DOI 10.1016/s0378-5955(03)00076-5, PubMed 12742236
Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia
Neurosci Lett, 340 (1), 69-73
DOI 10.1016/s0304-3940(03)00051-x, PubMed 12648761
The changing number of cells in the human fetal forebrain and its subdivisions: a stereological analysis
Cereb Cortex, 13 (2), 115-22
DOI 10.1093/cercor/13.2.115, PubMed 12507942
Regulation of the frontocortical sodium pump by Na+ in Alzheimer's disease: difference from the age-matched control but similarity to the rat model
FEBS Lett, 531 (2), 241-4
DOI 10.1016/s0014-5793(02)03510-x, PubMed 12417319
Possible signaling by glutathione and its novel analogue through potent stimulation of fontocortical G proteins in normal aging and in Alzheimer's disease
Ann N Y Acad Sci, 973, 537-40
DOI 10.1111/j.1749-6632.2002.tb04696.x, PubMed 12485924
Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice
Brain Res, 931 (2), 135-45
DOI 10.1016/s0006-8993(02)02268-0, PubMed 11897099
Loss of stimulatory effect of guanosine triphosphate on [(35)S]GTPgammaS binding correlates with Alzheimer's disease neurofibrillary pathology in entorhinal cortex and CA1 hippocampal subfield
J Neurosci Res, 67 (3), 388-98
DOI 10.1002/jnr.10125, PubMed 11813244
APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP(670, 671) mutation carriers: implications for late-onset Alzheimer's disease
J Cell Mol Med, 6 (2), 199-214
DOI 10.1111/j.1582-4934.2002.tb00187.x, PubMed 12169205
Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study
Dement Geriatr Cogn Disord, 13 (4), 205-12
DOI 10.1159/000057698, PubMed 12006730
Alive another day
J Cell Mol Med, 6 (4), 451-2
DOI 10.1111/j.1582-4934.2002.tb00448.x, PubMed 12611634
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model
Am J Pathol, 159 (6), 2215-25
DOI 10.1016/s0002-9440(10)63072-6, PubMed 11733371
On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells
Neurosci Lett, 314 (1-2), 45-8
DOI 10.1016/s0304-3940(01)02277-7, PubMed 11698143
Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders
Ann Neurol, 50 (5), 661-5
PubMed 11706973
Jargonagraphia in a case of frontotemporal dementia
Brain Lang, 79 (2), 333-9
DOI 10.1006/brln.2001.2491, PubMed 11712852
Expression of alpha-synuclein in the human brain: relation to Lewy body disease
Brain Res Mol Brain Res, 92 (1-2), 58-65
DOI 10.1016/s0169-328x(01)00150-4, PubMed 11483242
The total number of neurons and calcium binding protein positive neurons during aging in the cochlear nucleus of CBA/CaJ mice: a quantitative study
Hear Res, 158 (1-2), 102-15
DOI 10.1016/s0378-5955(01)00295-7, PubMed 11506942
Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease
Eur J Hum Genet, 9 (6), 437-44
DOI 10.1038/sj.ejhg.5200651, PubMed 11436125
The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defense
Neurochem Res, 26 (4), 353-61
DOI 10.1023/a:1010942929678, PubMed 11495345
The number of neurons in the inferior olivary nucleus in Alzheimer's disease and normal aging: A stereological study using the optical fractionator
J Alzheimers Dis, 3 (2), 159-168
DOI 10.3233/jad-2001-3201, PubMed 12214057
Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease
Dement Geriatr Cogn Disord, 12 (4), 243-50
DOI 10.1159/000051266, PubMed 11351135
Peripheral cell loss related to calcium binding protein immunocytochemistry in the dorsal cochlear nucleus in CBA/CaJ mice during aging
Audiol Neurootol, 6 (3), 132-9
DOI 10.1159/000046820, PubMed 11474139
Intraneuronal Lewy body inclusions in Parkinson and diffuse Lewy body disease
J Cell Mol Med, 5 (3), 318-9
DOI 10.1111/j.1582-4934.2001.tb00166.x, PubMed 12067491
The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex
Dement Geriatr Cogn Disord, 12 (6), 364-70
DOI 10.1159/000051282, PubMed 11598307
Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains
J Neural Transm (Vienna), 107 (8-9), 1085-97
DOI 10.1007/s007020070054, PubMed 11041284
Alzheimer's disease: plaques and tangles
J Cell Mol Med, 4 (4), 304-305
DOI 10.1111/j.1582-4934.2000.tb00131.x, PubMed 12067466
Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study
J Neural Transm (Vienna), 107 (4), 463-78
DOI 10.1007/s007020070088, PubMed 11215757
No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression
J Neural Transm (Vienna), 107 (8-9), 1065-79
DOI 10.1007/s007020070052, PubMed 11041282
Quantitative autoradiography of [3H]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits
Brain Res, 850 (1-2), 104-17
DOI 10.1016/s0006-8993(99)02111-3, PubMed 10629754
Ultrastructural analysis of the hippocampus of adult rats after long-term adrenalectomy
Brain Res, 849 (1-2), 226-30
DOI 10.1016/s0006-8993(99)02081-8, PubMed 10592306
The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains
Schizophr Res, 40 (1), 23-9
DOI 10.1016/s0920-9964(99)00037-7, PubMed 10541003
Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation
J Neurochem, 72 (3), 1161-9
DOI 10.1046/j.1471-4159.2000.0721161.x, PubMed 10037489
A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits
Brain Res, 818 (2), 383-96
DOI 10.1016/s0006-8993(98)01307-9, PubMed 10082824
Sound stimulation increases calcium-binding protein immunoreactivity in the inferior colliculus in mice
Neurosci Lett, 259 (1), 49-52
DOI 10.1016/s0304-3940(98)00911-2, PubMed 10027553
GABA transporters (GAT-1) in Alzheimer's disease
J Neural Transm (Vienna), 106 (11-12), 1141-9
DOI 10.1007/s007020050230, PubMed 10651110
A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease
Dement Geriatr Cogn Disord, 10 (6), 452-9
DOI 10.1159/000017189, PubMed 10559559
The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia
J Mol Neurosci, 13 (1-2), 101-9
DOI 10.1385/JMN:13:1-2:101, PubMed 10691297
Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease
Exp Neurol, 154 (2), 511-21
DOI 10.1006/exnr.1998.6892, PubMed 9878186
HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy
Nat Med, 4 (10), 1182-4
DOI 10.1038/2677, PubMed 9771753
Alzheimer changes are common in aged drivers killed in single car crashes and at intersections
Forensic Sci Int, 96 (2-3), 115-27
DOI 10.1016/s0379-0738(98)00114-5, PubMed 9854829
Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine
Brain Res, 801 (1-2), 143-9
DOI 10.1016/s0006-8993(98)00558-7, PubMed 9729344
Modulating calbindin and parvalbumin immunoreactivity in the cochlear nucleus by moderate noise exposure in mice. . A quantitative study on the dorsal and posteroventral cochlear nucleus
Brain Res, 800 (1), 86-96
DOI 10.1016/s0006-8993(98)00504-6, PubMed 9685593
Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration
Brain Res, 797 (2), 267-77
DOI 10.1016/s0006-8993(98)00296-0, PubMed 9666145
Changes in IGF-1 receptors in the hippocampus of adult rats after long-term adrenalectomy: receptor autoradiography and in situ hybridization histochemistry
Brain Res, 797 (2), 342-6
DOI 10.1016/s0006-8993(98)00389-8, PubMed 9666167
Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology
Brain Res, 796 (1-2), 209-21
DOI 10.1016/s0006-8993(98)00347-3, PubMed 9689471
Polymorphic expression of multidrug resistance mRNA in lung parenchyma of nonpregnant and pregnant rats: a comparison to cystic fibrosis mRNA expression
Biochem Biophys Res Commun, 239 (2), 606-11
DOI 10.1006/bbrc.1997.7519, PubMed 9344878
Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes
Neurosci Lett, 232 (1), 37-40
DOI 10.1016/s0304-3940(97)00573-9, PubMed 9292886
Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease
J Comp Neurol, 379 (4), 482-94
DOI 10.1002/(sici)1096-9861(19970324)379:4<482::aid-cne2>3.0.co;2-z, PubMed 9067838
Cystic fibrosis mRNA expression in rat brain: cerebral cortex and medial preoptic area
Neuroreport, 8 (2), 535-9
DOI 10.1097/00001756-199701200-00031, PubMed 9080443
Localization of M1 muscarinic receptors in rat brain using selective muscarinic toxin-1
Brain Res Bull, 44 (5), 597-601
DOI 10.1016/s0361-9230(97)00281-5, PubMed 9365803
Autoradiographic characterization of [3H]inositol (1,4,5) trisphosphate and [3H]inositol (1,3,4,5) tetrakisphosphate binding sites in human brain
J Neural Transm (Vienna), 104 (2-3), 175-89
DOI 10.1007/BF01273179, PubMed 9203080
Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains
Neurobiol Aging, 18 (1), 121-7
DOI 10.1016/s0197-4580(96)00204-7, PubMed 8983040
Elevated protein levels of protein phosphatases PP-2A and PP-2B in astrocytes of Alzheimer's disease temporal cortex
J Neural Transm (Vienna), 104 (11-12), 1329-38
DOI 10.1007/BF01294734, PubMed 9503279
Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls
Brain Res, 722 (1-2), 71-7
DOI 10.1016/0006-8993(96)00183-7, PubMed 8813351
Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene
Am J Pathol, 148 (4), 1257-66
PubMed 8644866
Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele
J Neural Transm (Vienna), 103 (5), 603-18
DOI 10.1007/BF01273157, PubMed 8811505
Prolactin binding sites in rat brain and liver: effects of long-term ovariectomy and ovarian steroids
Neurosci Lett, 200 (3), 179-82
DOI 10.1016/0304-3940(95)12106-e, PubMed 9064606
Effects of long-term ovariectomy and ovarian steroids on somatogenic binding sites in rat brain and liver
Neurosci Lett, 194 (3), 193-6
DOI 10.1016/0304-3940(95)11759-p, PubMed 7478236
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain
Neuron, 15 (1), 219-28
DOI 10.1016/0896-6273(95)90079-9, PubMed 7619525
Loss of neurones after long-term adrenalectomy in the adult rat hippocampal formation
Neuroreport, 5 (17), 2285-8
DOI 10.1097/00001756-199411000-00020, PubMed 7881047
Somatogenic and lactogenic binding sites in rat brain and liver: quantitative autoradiographic localization
Neurosci Res, 20 (3), 257-63
DOI 10.1016/0168-0102(94)90095-7, PubMed 7838426
Decrease of somatostatin receptor binding in the rat cerebral cortex after ibotenic acid lesion of the nucleus basalis magnocellularis: a quantitative autoradiographic study
Brain Res, 628 (1-2), 31-8
DOI 10.1016/0006-8993(93)90934-f, PubMed 8313162
Effects of nucleus basalis lesion on muscarinic receptor subtypes
Exp Brain Res, 97 (2), 225-32
DOI 10.1007/BF00228691, PubMed 8150042
[Miliary tuberculosis of the lungs]
Srp Arh Celok Lek, 121 (8-12), 143-6
PubMed 7725157
[Analysis of hospitalized tuberculosis patients at the Institute for Pulmonary Diseases and Tuberculosis in Belgrade, Serbia during 1988]
Plucne Bolesti, 42 (1-2), 117-22
PubMed 2217622
Structural basis of the developmental plasticity in the human cerebral cortex: the role of the transient subplate zone
Metab Brain Dis, 4 (1), 17-23
DOI 10.1007/BF00999489, PubMed 2649779
Cytoarchitectonic parameters of developmental capacity of the human associative auditory cortex during postnatal life
Acta Otolaryngol, 105 (5-6), 463-6
DOI 10.3109/00016488809119502, PubMed 2456663
[The clinical importance at the present time of the tuberculin test in adults]
Plucne Bolesti, 36 (1-2), 80-3
PubMed 6514853
Review articles
Cerebral ABC transporter-common mechanisms may modulate neurodegenerative diseases and depression in elderly subjects
Arch Med Res, 45 (8), 738-43
DOI 10.1016/j.arcmed.2014.10.010, PubMed 25446622
Pathways to Alzheimer's disease
J Intern Med, 275 (3), 296-303
DOI 10.1111/joim.12192, PubMed 24749173
Blood-brain barrier alterations in ageing and dementia
J Neurol Sci, 283 (1-2), 99-106
DOI 10.1016/j.jns.2009.02.321, PubMed 19264328
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium
Acta Neuropathol, 115 (5), 497-507
DOI 10.1007/s00401-008-0360-8, PubMed 18365220
Environmental enrichment and the brain
Prog Brain Res, 138, 109-33
DOI 10.1016/S0079-6123(02)38074-9, PubMed 12432766
Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging
Exp Gerontol, 35 (6-7), 851-64
DOI 10.1016/s0531-5565(00)00147-9, PubMed 11053676
The role of APOE polymorphisms in late-onset dementias
Cell Mol Life Sci, 54 (9), 928-34
DOI 10.1007/s000180050223, PubMed 9791536
Multiple sclerosis and amyloid deposits in the white matter of the brain
Acta Neuropathol, 93 (2), 205-9
DOI 10.1007/s004010050604, PubMed 9039470
Other articles
Correction: Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains
Mol Psychiatry (in press)
DOI 10.1038/s41380-023-02021-2, PubMed 36890300
[Not Available]
Lakartidningen, 115
PubMed 29558009
[Not Available]
Tidsskr Nor Laegeforen, 137 (10), 685
DOI 10.4045/tidsskr.17.0388, PubMed 28551955
Excellent outcome of pallidal deep brain stimulation in DYT6 dystonia: A case report
J Neurol Sci, 366, 18-19
DOI 10.1016/j.jns.2016.04.032, PubMed 27288769
Erratum to: Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium
J Neural Transm (Vienna), 122 (7), 973-4
DOI 10.1007/s00702-014-1337-5, PubMed 25418279
Cerebral arteriolar pathology in a 32-year-old patient with CADASIL
Neuropathol Appl Neurobiol, 32 (4), 455-8
DOI 10.1111/j.1365-2990.2006.00746.x, PubMed 16866991
Alzheimer's disease and apolipoprotein E epsilon 4 allele in older drivers who died in automobile accidents
Lancet, 349 (9059), 1143-4
DOI 10.1016/S0140-6736(97)24016-X, PubMed 9113015
Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family
Neurosci Lett, 168 (1-2), 254-6
DOI 10.1016/0304-3940(94)90463-4, PubMed 8028788